Open AccessReal-World Effectiveness, Treatment Pattern, and Safety of Ranibizumab in Korean Patients with Neovascular Age-Related Macular Degeneration: Subgroup Analyses from the LUMINOUS Study
Author(s) -
Min Sagong,
Se Joon Woo,
Youkyung Lee
Publication year - 2021
Publication title -
clinical ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 56
eISSN - 1177-5483
pISSN - 1177-5467
DOI - 10.2147/opth.s303884
Subject(s) - medicine , ranibizumab , macular degeneration , ophthalmology , visual acuity , diabetic retinopathy , adverse effect , odds ratio , choroidal neovascularization , prospective cohort study , bevacizumab , diabetes mellitus , chemotherapy , endocrinology
To evaluate the real-world effectiveness, treatment patterns, and safety of ranibizumab in Korean patients with neovascular age-related macular degeneration (nAMD).